Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy.

Liu, Weilin; Chen, Hongqi; Zhu, Zhi; Liu, Zuqiang; Ma, Congrong; Lee, Yong J; Bartlett, David L; Guo, Zong-Sheng

Liu, Weilin; Chen, Hongqi; Zhu, Zhi; Liu, Zuqiang; Ma, Congrong; Lee, Yong J; Bartlett, David L; Guo, Zong-Sheng.

Afiliación

Liu W; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Chen H; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
Zhu Z; Xiangya Medical College, Central South University, Changsha 410013, China.
Liu Z; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Ma C; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
Lee YJ; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Bartlett DL; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
Guo ZS; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Biomedicines ; 10(6)2022 Jun 15.

Article en En | MEDLINE | ID: mdl-35740445

Palabras clave

T cells; antitumor immunity; combination; dendritic cells; efficacy; erastin; ferroptosis; immunotherapy; oncolytic virus; stimulator

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google